These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38516779)

  • 1. Association between monoclonal antibody therapy, vaccination, and longer-term symptom resolution after acute COVID-19.
    Roberts SC; Jolley SE; Beaty LE; Aggarwal NR; Bennett TD; Carlson NE; Fish LE; Kwan BM; Russell S; Wogu AF; Wynia MA; Ginde AA
    J Med Virol; 2024 Mar; 96(3):e29541. PubMed ID: 38516779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-world effectiveness of COVID-19 vaccines and anti-SARS-CoV-2 monoclonal antibodies against postacute sequelae of SARS-CoV-2: analysis of a COVID-19 observational registry for a diverse US metropolitan population.
    Tannous J; Pan AP; Potter T; Bako AT; Dlouhy K; Drews A; Sostman HD; Vahidy FS
    BMJ Open; 2023 Apr; 13(4):e067611. PubMed ID: 37019490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal Antibodies for Treatment of SARS-CoV-2 Infection During Pregnancy : A Cohort Study.
    McCreary EK; Lemon L; Megli C; Oakes A; Seymour CW;
    Ann Intern Med; 2022 Dec; 175(12):1707-1715. PubMed ID: 36375150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study.
    Antonelli M; Penfold RS; Merino J; Sudre CH; Molteni E; Berry S; Canas LS; Graham MS; Klaser K; Modat M; Murray B; Kerfoot E; Chen L; Deng J; Österdahl MF; Cheetham NJ; Drew DA; Nguyen LH; Pujol JC; Hu C; Selvachandran S; Polidori L; May A; Wolf J; Chan AT; Hammers A; Duncan EL; Spector TD; Ourselin S; Steves CJ
    Lancet Infect Dis; 2022 Jan; 22(1):43-55. PubMed ID: 34480857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between treatment failure and hospitalization after receipt of neutralizing monoclonal antibody treatment for COVID-19 outpatients.
    Douin DJ; Wogu AF; Beaty LE; Carlson NE; Bennett TD; Aggarwal NR; Mayer DA; Ong TC; Russell S; Steele J; Peers JL; Molina KC; Wynia MK; Ginde AA
    BMC Infect Dis; 2022 Nov; 22(1):818. PubMed ID: 36344927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolving Real-World Effectiveness of Monoclonal Antibodies for Treatment of COVID-19 : A Cohort Study.
    Kip KE; McCreary EK; Collins K; Minnier TE; Snyder GM; Garrard W; McKibben JC; Yealy DM; Seymour CW; Huang DT; Bariola JR; Schmidhofer M; Wadas RJ; Angus DC; Kip PL; Marroquin OC
    Ann Intern Med; 2023 Apr; 176(4):496-504. PubMed ID: 37011399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timely course of SARS-CoV-2 infections and vaccinations in patients with hemato-oncological diseases: analysis of a real-life cohort.
    Mair MJ; Mitterer M; Buratti T; Berchtold L; Fong D; Preusser M
    ESMO Open; 2023 Jun; 8(3):101559. PubMed ID: 37196399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Rituximab Use, Time Between Rituximab and SARS-CoV-2 Vaccination, and COVID-19 Hospitalization or Death in Patients With Multiple Sclerosis.
    Smith JB; Gonzales EG; Li BH; Langer-Gould A
    JAMA Netw Open; 2022 Dec; 5(12):e2248664. PubMed ID: 36576740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal adaptive immune responses following sequential SARS-CoV-2 vaccinations in MS patients on anti-CD20 therapies and sphingosine-1-phosphate receptor modulators.
    Sabatino JJ; Mittl K; Rowles W; Zamecnik CR; Loudermilk RP; Gerungan C; Spencer CM; Sagan SA; Alexander J; Mcpolin K; Chen P; Deshpande C; Wyse K; Maiese EM; Wilson MR; Zamvil SS; Bove R
    Mult Scler Relat Disord; 2023 Feb; 70():104484. PubMed ID: 36608538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coverage and Estimated Effectiveness of mRNA COVID-19 Vaccines Among US Veterans.
    Young-Xu Y; Korves C; Roberts J; Powell EI; Zwain GM; Smith J; Izurieta HS
    JAMA Netw Open; 2021 Oct; 4(10):e2128391. PubMed ID: 34613401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study.
    Babouee Flury B; Güsewell S; Egger T; Leal O; Brucher A; Lemmenmeier E; Meier Kleeb D; Möller JC; Rieder P; Rütti M; Schmid HR; Stocker R; Vuichard-Gysin D; Wiggli B; Besold U; McGeer A; Risch L; Friedl A; Schlegel M; Kuster SP; Kahlert CR; Kohler P;
    PLoS Med; 2022 Nov; 19(11):e1004125. PubMed ID: 36342956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On variants and vaccines: The effectiveness of Covid-19 monoclonal antibody therapy during two distinct periods in the pandemic.
    Srinivasan V; Weinstein SE; Bhimani A; Clemons NC; Dinolfo M; Shin CS; Grier J; Lopez A; Braggs J; Boucher J; Batiste QN; Garner OB; Yang S; Vijayan T
    PLoS One; 2022; 17(12):e0278394. PubMed ID: 36454767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 Infection.
    Richard SA; Pollett SD; Fries AC; Berjohn CM; Maves RC; Lalani T; Smith AG; Mody RM; Ganesan A; Colombo RE; Lindholm DA; Morris MJ; Huprikar N; Colombo CJ; Madar C; Jones M; Larson DT; Bazan SE; Mende K; Saunders D; Livezey J; Lanteri CA; Scher AI; Byrne C; Rusiecki J; Ewers E; Epsi NJ; Rozman JS; English C; Simons MP; Tribble DR; Agan BK; Burgess TH;
    JAMA Netw Open; 2023 Jan; 6(1):e2251360. PubMed ID: 36652247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors Associated With Severe COVID-19 Among Vaccinated Adults Treated in US Veterans Affairs Hospitals.
    Vo AD; La J; Wu JT; Strymish JM; Ronan M; Brophy M; Do NV; Branch-Elliman W; Fillmore NR; Monach PA
    JAMA Netw Open; 2022 Oct; 5(10):e2240037. PubMed ID: 36264571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between SARS-CoV-2 infection and select symptoms and conditions 31 to 150 days after testing among children and adults.
    Zhang Y; Romieu-Hernandez A; Boehmer TK; Azziz-Baumgartner E; Carton TW; Gundlapalli AV; Fearrington J; Nagavedu K; Dea K; Moyneur E; Cowell LG; Kaushal R; Mayer KH; Puro J; Rasmussen SA; Thacker D; Weiner MG; Saydah S; Block JP;
    BMC Infect Dis; 2024 Feb; 24(1):181. PubMed ID: 38341566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-World Evidence of Neutralizing Monoclonal Antibodies for Preventing Hospitalization and Mortality in COVID-19 Outpatients.
    Wynia MK; Beaty LE; Bennett TD; Carlson NE; Davis CB; Kwan BM; Mayer DA; Ong TC; Russell S; Steele JD; Stocker HR; Wogu AF; Zane RD; Sokol RJ; Ginde AA
    Chest; 2023 May; 163(5):1061-1070. PubMed ID: 36441040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19.
    Hirsch C; Park YS; Piechotta V; Chai KL; Estcourt LJ; Monsef I; Salomon S; Wood EM; So-Osman C; McQuilten Z; Spinner CD; Malin JJ; Stegemann M; Skoetz N; Kreuzberger N
    Cochrane Database Syst Rev; 2022 Jun; 6(6):CD014945. PubMed ID: 35713300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of complementary medicine and its association with SARS-CoV-2 vaccination during the COVID-19 pandemic: a longitudinal cohort study.
    Nehme M; Braillard O; Rodondi PY; Guessous I
    Swiss Med Wkly; 2023 Dec; 153():3505. PubMed ID: 38579302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 vaccination, ABO blood group and risk of COVID-19: population-based cohort study.
    Ray JG; Park AL
    BMJ Open; 2022 Jul; 12(7):e059944. PubMed ID: 35851010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between SARS-CoV-2 Infection and Select Symptoms and Conditions 31 to 150 Days After Testing among Children and Adults.
    Zhang Y; Romieu-Hernandez A; Boehmer TK; Azziz-Baumgartner E; Carton TW; Gundlapalli AV; Fearrington J; Nagavedu K; Dea K; Moyneur E; Cowell LG; Kaushal R; Mayer KH; Puro J; Rasmussen SA; Thacker D; Weiner MG; Saydeh S; Block JP;
    medRxiv; 2022 Dec; ():. PubMed ID: 36597540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.